Recordati Polskasp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-03-20
Share capital
4,500,000.00 PLN
Registered address
Aleja Armii Ludowej 26, 00-609 Warszawa, Poland
Phone
Social media
Electronic delivery address
AE:PL-91782-87029-BIWCT-27

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 97 days early. All were audited by a statutory auditor.

  • 202522/04/2026
  • 202422/04/2025
  • 202312/04/2024
  • 202218/05/2023
  • 202119/04/2022
  • 202023/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 9.8%
Sector · Manufacturing843 / 24,479
Top 3.4%
City · Warszawa732 / 56,980
Top 1.3%
Voivodeship · Mazowieckie944 / 77,137
Top 1.2%
Country · Poland2,652 / 297,935
Top <1%

Results vs industry

Revenue
This companyUSD 85.90mMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD 8.71mMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 74.18mMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 48.74mMedianUSD 897.46kAverageUSD 31.52m

Trademarks

Recordati Polska holds 32 active trademarks registered with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 2005.

MarkNumberClassesStatusProtected until
GRANMESA(word)Z.5837375Protected Apr 25, 2035
SALMESAL(word)Z.5835245Protected Apr 22, 2035
Abiregard(word)Z.5452525Protected Jul 18, 2032
RECOBUTARIN(word)Z.5241315Protected Feb 4, 2031
REBUTESTIN(word)Z.5241325Protected Feb 4, 2031
MarkProtected until
GRANMESA(word)Apr 25, 2035
SALMESAL(word)Apr 22, 2035
Abiregard(word)Jul 18, 2032
RECOBUTARIN(word)Feb 4, 2031
REBUTESTIN(word)Feb 4, 2031

Authorized Representatives

Janusz Andrzej Gaudnik – Management Board Member
Christophe Defoux – Management Board Member
Witold Franciszek Urban – President of the Management Board

Manner of representation

The company is represented vis-à-vis third parties as follows: a) by the President of the Management Board acting independently; or b) by any member of the management board, other than the President of the Management Board, acting: - independently, if the value of the transaction (including disposal of a right or incurring an obligation) does not exceed PLN 850,000; or - jointly with the President of the Management Board, if the value of the transaction (including disposal of a right or incurring an obligation) exceeds PLN 850,000.

Ownership

OwnerSharesShare valueStake
Recordati Industria Chimica E Farmaceutica S.p.a.
90,000$1,215,559.16100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2002-03-20.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 26,550

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$0

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Anpharm Przedsiębiorstwo FarmaceutyczneS.A.
Sciencepharmasp. z o.o.
Delpharm PoznańS.A.
Tarchomińskie Zakłady Farmaceutyczne PolfaS.A.
ICN Polfa RzeszówS.A.
Synoptis Pharmasp. z o.o.
PolfarmexS.A.
BiotonS.A.
Celon PharmaS.A.
SUN-Farmsp. z o.o.

Change history

DateEvent
2023-07-03Address change
2014-12-31Share capital increase
2014-01-02Address change
2014-01-02Name change
2013-08-05Share capital increase

FAQ

Last updated: 2026-10-07